Cardiff Oncology(DE:XE7C)
€0.64-0.01 (-1.69%)
DE:XE7C
Cardiff Oncology earnings date
€0.64
At close:-0.01 (-1.69%)
Cardiff Oncology (XE7C) Q4 2023 Earnings Report
3 Followers
DE:XE7C Q4 2023 EPS Results
- Actual EPS
- -EUR 0.19
- Consensus EPS
- -EUR 0.24
- Beat/Miss
- Beat by +EUR 0.05
- One Year Ago EPS
- -EUR 0.18
DE:XE7C Q4 2023 Revenue Results
- Actual Revenue
- EUR 141.01K
- Expected Revenue
- EUR 45.20K
- Beat/Miss
- Beat by +EUR 95.82K
- YoY Revenue Growth
- +21.87%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/29/2024
- Time
- After Close
- Conference Call
- Thursday, February 29, 2024
DE:XE7C Upcoming Earnings
Cardiff Oncology's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:XE7C Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:XE7C Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.12- | -0.1 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.12-0.11 | -0.15 | 29.41% (+0.05) | |
| Aug 11, 2026 | 2026 (Q2) | -0.11-0.13 | -0.19 | 33.33% (+0.06) | |
| May 14, 2026 | 2026 (Q1) | -0.12-0.16 | -0.18 | 10.00% (+0.02) | |
| Feb 24, 2026 | 2025 (Q4) | -0.17-0.10 | -0.2 | 50.00% (+0.10) | |
| Nov 06, 2025 | 2025 (Q3) | -0.19-0.15 | -0.23 | 32.00% (+0.07) | |
| Jul 29, 2025 | 2025 (Q2) | -0.17-0.19 | -0.24 | 19.23% (+0.05) | |
| May 08, 2025 | 2025 (Q1) | -0.17-0.18 | -0.2 | 9.09% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -0.22-0.20 | -0.19 | -4.76% (-0.01) | |
| Nov 07, 2024 | 2024 (Q3) | -0.24-0.23 | -0.2 | -13.64% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
